Profil
Scott Lauder worked as VP-Process Sciences & Clinical Manufacturing at Merrimack Pharmaceuticals, Inc. from 2013 to 2016.
He then worked as Chief Technology Officer at Gemini Therapeutics, Inc. from 2016 to 2021.
Lauder holds a doctorate degree from Northwestern University and an undergraduate degree from the University of Manitoba.
Ehemalige bekannte Positionen von Scott Lauder
Unternehmen | Position | Ende |
---|---|---|
GEMI THER | Technik-/Wissenschafts-/F&E-Leiter | 17.09.2021 |
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2016 |
Ausbildung von Scott Lauder
University of Manitoba | Undergraduate Degree |
Northwestern University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |